Sriven Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 31-07-2024
- Paid Up Capital ₹ 2.00 M
as on 31-07-2024
- Company Age 25 Year, 21 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 Cr
as on 31-07-2024
- Revenue %
(FY 2023)
- Profit -80.90%
(FY 2023)
- Ebitda -101.47%
(FY 2023)
- Net Worth -22.73%
(FY 2023)
- Total Assets -3.91%
(FY 2023)
About Sriven Life Science
The Corporate was formerly known as Sriven Metals And Alloys Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.10 Cr.
Veera Gutta and Indira Kadiyala serve as directors at the Company.
- CIN/LLPIN
U27109TG1999PTC033135
- Company No.
033135
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sriven Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veera Gutta  | Director | 24-Dec-1999 | Current |
| Indira Kadiyala | Director | 31-Oct-2003 | Current |
Financial Performance of Sriven Life Science.
Sriven Life Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 80.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sriven Life Science?
In 2023, Sriven Life Science had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Dec 2014 | ₹4.20 M | Open |
State Bank Of Hyderabad Creation Date: 18 Mar 2002 | ₹3.40 M | Open |
State Bank Of Hyderabad Creation Date: 18 Mar 2002 | ₹3.40 M | Open |
How Many Employees Work at Sriven Life Science?
Unlock and access historical data on people associated with Sriven Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sriven Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sriven Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
